메뉴 건너뛰기




Volumn 18, Issue 1, 2013, Pages 253-260

The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro

Author keywords

Apoptotic index; Cancer; Mitotic index; Sunitinib; Sutent; Targeted cancer therapy

Indexed keywords

SUNITINIB;

EID: 84878989187     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (30)
  • 1
    • 0009655168 scopus 로고    scopus 로고
    • Characteristics of human cancer
    • Ruddon RW(Ed): (4th Edn). Oxford University Press, New York
    • Ruddon RW. Characteristics of human cancer. In: Ruddon RW(Ed): Cancer Biology (4th Edn). Oxford University Press, New York, 2007, pp 3-61.
    • (2007) Cancer Biology , pp. 3-61
    • Ruddon, R.W.1
  • 3
    • 77953143235 scopus 로고    scopus 로고
    • Targeted Cancer Therapies
    • Aggarwal S. Targeted Cancer Therapies. Nature Rev, Drug Discov 2010; 9: 427-428.
    • (2010) Nature Rev, Drug Discov , vol.9 , pp. 427-428
    • Aggarwal, S.1
  • 4
    • 59649129538 scopus 로고    scopus 로고
    • Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-Glycoprotein (ABCB1) and ABCG2
    • Shukla S, Robey RW, Bates SE, Ambudkar SV. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-Glycoprotein (ABCB1) and ABCG2. Drug Metabol Dispos 2008; 37: 359-365.
    • (2008) Drug Metabol Dispos , vol.37 , pp. 359-365
    • Shukla, S.1    Robey, R.W.2    Bates, S.E.3    Ambudkar, S.V.4
  • 5
    • 65249087328 scopus 로고    scopus 로고
    • A population pharmacokinetic meta-analysis of Sunitinib Malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients
    • Houk BE, Bello CL, Kang D, Amantea M. A population pharmacokinetic meta-analysis of Sunitinib Malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients. Clin Cancer Res 2009; 15: 2497-2506.
    • (2009) Clin Cancer Res , vol.15 , pp. 2497-2506
    • Houk, B.E.1    Bello, C.L.2    Kang, D.3    Amantea, M.4
  • 6
    • 33947416658 scopus 로고    scopus 로고
    • Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
    • Roskoski R Jr. Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun 2007; 356: 323-328.
    • (2007) Biochem Biophys Res Commun , vol.356 , pp. 323-328
    • Roskoski Jr., R.1
  • 7
    • 62549157391 scopus 로고    scopus 로고
    • Induction of apoptosis and cell proliferation inhibition by paclitaxel in FM3A cell cultures
    • Ilgar NN, Arican Ozcan G. Induction of apoptosis and cell proliferation inhibition by paclitaxel in FM3A cell cultures. Afr J Biotechnol 2008; 8: 547-555.
    • (2008) Afr J Biotechnol , vol.8 , pp. 547-555
    • Ilgar, N.N.1    Arican Ozcan, G.2
  • 8
    • 0017088883 scopus 로고
    • Apparent anomalies in nuclear Feulgen-DNA contents
    • Bedi KS, Goldstein DJ. Apparent anomalies in nuclear Feulgen-DNA contents. J Cell Biol 1976; 71: 68-88.
    • (1976) J Cell Biol , vol.71 , pp. 68-88
    • Bedi, K.S.1    Goldstein, D.J.2
  • 9
    • 0019307591 scopus 로고
    • Mechanisms of the Feulgen acid hydrolysis
    • Kjellstrand P. Mechanisms of the Feulgen acid hydrolysis. J Microscopy 1980; 119: 391-396. (Pubitemid 10010604)
    • (1980) Journal of Microscopy , vol.119 , Issue.3 , pp. 391-396
    • Kjellstrand, P.1
  • 10
    • 33645364706 scopus 로고    scopus 로고
    • Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC)
    • abstr
    • Miller KD, Burstein HJ, Elias AD et al. Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC). J Clin Oncol 2005; 23 (Suppl): 563 (abstr).
    • (2005) J Clin Oncol , vol.23 , Issue.SUPPL. , pp. 563
    • Miller, K.D.1    Burstein, H.J.2    Elias, A.D.3
  • 11
    • 33845297206 scopus 로고    scopus 로고
    • Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial
    • abstr
    • Socinski MA, Novello S, Sanchez JM et al. Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial. J Clin Oncol 2006; 24 (Suppl): 7001 (abstr).
    • (2006) J Clin Oncol , vol.24 , Issue.SUPPL. , pp. 7001
    • Socinski, M.A.1    Novello, S.2    Sanchez, J.M.3
  • 12
    • 28044447317 scopus 로고    scopus 로고
    • A phase 2 study to evaluate the efficacy and safety of SU11248 in patients (pts) with unresectable neuroendocrine tumors (NETs)
    • abstr
    • Kulke M, Lenz HJ, Meropol NJ et al. A phase 2 study to evaluate the efficacy and safety of SU11248 in patients (pts) with unresectable neuroendocrine tumors (NETs). J Clin Oncol 2005; 23 (Suppl): 4008 (abstr).
    • (2005) J Clin Oncol , vol.23 , Issue.SUPPL. , pp. 4008
    • Kulke, M.1    Lenz, H.J.2    Meropol, N.J.3
  • 14
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 15
    • 33749544080 scopus 로고    scopus 로고
    • An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/Papillary thyroid cancer kinases
    • Kim WD, Jo SY, Jung SH et al. An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/Papillary thyroid cancer kinases. J Clin Endocrinol Metabol 2006; 91: 4070-4076.
    • (2006) J Clin Endocrinol Metabol , vol.91 , pp. 4070-4076
    • Kim, W.D.1    Jo, S.Y.2    Jung, S.H.3
  • 16
    • 38449097166 scopus 로고    scopus 로고
    • Antiangiogenic and antiinvasive effects of sunitinib on experimental human glioblastoma
    • De Boüard S, Herlin P, Christensen JG et al. Antiangiogenic and antiinvasive effects of sunitinib on experimental human glioblastoma. Neuro Oncol 2007; 9: 412-423.
    • (2007) Neuro Oncol , vol.9 , pp. 412-423
    • De Boüard, S.1    Herlin, P.2    Christensen, J.G.3
  • 17
    • 2442669093 scopus 로고    scopus 로고
    • Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "Standard of care" therapeutic agents for the treatment of breast cancer
    • Abrams TJ, Murray LJ, Pesenti E et al. Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "Standard of care" therapeutic agents for the treatment of breast cancer. Mol Cancer Ther 2003; 2: 1011-1021.
    • (2003) Mol Cancer Ther , vol.2 , pp. 1011-1021
    • Abrams, T.J.1    Murray, L.J.2    Pesenti, E.3
  • 18
    • 84879007189 scopus 로고    scopus 로고
    • Correlation of receptor tyrosine kinase (RTK) activity and apoptosis with response to sunitinib treatment in patients with gastrointestinal stromal tumor (GIST)
    • Davis DW, Heymach JV, Desai J et al. Correlation of receptor tyrosine kinase (RTK) activity and apoptosis with response to sunitinib treatment in patients with gastrointestinal stromal tumor (GIST). 18th EORTC-NCI-AACR Symposium Presentations, 2006, Prague, Czech Republic.
    • 18th EORTC-NCI-AACR Symposium Presentations, 2006, Prague, Czech Republic
    • Davis, D.W.1    Heymach, J.V.2    Desai, J.3
  • 23
    • 67649354223 scopus 로고    scopus 로고
    • Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model
    • Sonpavde G, Jian W, Liu H, Wu MF, Shen SS, Lerner SP. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model. Urol Oncol 2009; 27: 391-399.
    • (2009) Urol Oncol , vol.27 , pp. 391-399
    • Sonpavde, G.1    Jian, W.2    Liu, H.3    Wu, M.F.4    Shen, S.S.5    Lerner, S.P.6
  • 26
    • 0000980730 scopus 로고
    • The fusion of broken ends of chromosomes following nuclear fusion
    • McClintock B. The fusion of broken ends of chromosomes following nuclear fusion. Proc Natl Acad Sci USA 1942; 28: 458-463.
    • (1942) Proc Natl Acad Sci USA , vol.28 , pp. 458-463
    • McClintock, B.1
  • 27
    • 0031004175 scopus 로고    scopus 로고
    • Genetic instability in colorectal cancers
    • DOI 10.1038/386623a0
    • Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997; 386: 623-627. (Pubitemid 27175430)
    • (1997) Nature , vol.386 , Issue.6625 , pp. 623-627
    • Lengauer, C.1    Kinzler, K.W.2    Vogelstein, B.3
  • 28
    • 0037188898 scopus 로고    scopus 로고
    • Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations
    • DOI 10.1016/S0092-8674(02)00770-5
    • Zhu C, Mills KD, Ferguson DO et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002; 109: 811-821. (Pubitemid 34785997)
    • (2002) Cell , vol.109 , Issue.7 , pp. 811-821
    • Zhu, C.1    Mills, K.D.2    Ferguson, D.O.3    Lee, C.4    Manis, J.5    Fleming, J.6    Gao, Y.7    Morton, C.C.8    Alt, F.W.9
  • 29
    • 0034978564 scopus 로고    scopus 로고
    • Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
    • DOI 10.1038/88871
    • Rudolph KL, Millard M, Bosenberg MW, Depinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001; 28: 155-159. (Pubitemid 32538061)
    • (2001) Nature Genetics , vol.28 , Issue.2 , pp. 155-159
    • Rudolph, K.L.1    Millard, M.2    Bosenberg, M.W.3    DePinho, R.A.4
  • 30
    • 0034632717 scopus 로고    scopus 로고
    • Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
    • DOI 10.1038/35020592
    • Artandi SE, Chang S, Lee SL et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641-645. (Pubitemid 30641052)
    • (2000) Nature , vol.406 , Issue.6796 , pp. 641-645
    • Artandl, S.E.1    Chang, S.2    Lee, S.-L.3    Alson, S.4    Gottlieb, G.J.5    Chin, L.6    DePinho, R.A.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.